Oracle Corporation (ORCL) Stock Forecast
Data as of Oct 31, 2026Technology · Current price $129.40 (-7.33%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 11, 2026 | Brad Zelnick | Deutsche Bank | $300.00 | +131.8% |
| Mar 11, 2026 | Rishi Jaluria | RBC Capital | $160.00 | +23.6% |
| Mar 11, 2026 | Brad Reback | Stifel Nicolaus | $220.00 | +70.0% |
| Mar 9, 2026 | Thomas Blakey | Cantor Fitzgerald | $229.00 | +77.0% |
| Mar 9, 2026 | Raimo Lenschow | Barclays | $230.00 | +77.7% |
| Mar 5, 2026 | Brent Thill | Jefferies | $320.00 | +147.3% |
| Feb 9, 2026 | Ben Reitzes | Melius Research | $160.00 | +23.6% |
| Jan 5, 2026 | Rishi Jaluria | RBC Capital | $195.00 | +50.7% |
| Dec 15, 2025 | Siti Panigrahi | Mizuho Securities | $400.00 | +209.1% |
| Dec 12, 2025 | Kash Rangan | Goldman Sachs | $220.00 | +70.0% |
| Dec 11, 2025 | Jackson Ader | KeyBanc | $300.00 | +131.8% |
| Dec 11, 2025 | Brad Reback | Stifel Nicolaus | $275.00 | +112.5% |
| Dec 11, 2025 | Raimo Lenschow | Barclays | $310.00 | +139.6% |
| Dec 11, 2025 | Pat Colville | Scotiabank | $260.00 | +100.9% |
| Dec 5, 2025 | Rishi Jaluria | RBC Capital | $310.00 | +139.6% |
| Nov 26, 2025 | Stephen Bersey | HSBC | $382.00 | +195.2% |
| Nov 26, 2025 | Brad Zelnick | Deutsche Bank | $375.00 | +189.8% |
| Nov 25, 2025 | Gil Luria | D.A. Davidson | $200.00 | +54.6% |
| Oct 17, 2025 | Patrick Colville | Scotiabank | $360.00 | +178.2% |
| Oct 17, 2025 | Brett Huff | Stephens | $331.00 | +155.8% |
Top Analysts Covering ORCL
ORCL vs Sector & Market
| Metric | ORCL | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.14 | 2.39 | 2.41 |
| Analyst Count | 51 | 14 | 19 |
| Target Upside | +78.4% | +3582.4% | +21.5% |
| P/E Ratio | 22.20 | 40.47 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-05-31 | $85.49B | $88.61B | $89.84B | 29 |
| 2028-05-31 | $129.44B | $129.79B | $130.14B | 35 |
| 2028-08-28 | $38.49B | $39.77B | $40.46B | 14 |
| 2028-11-28 | $42.50B | $43.91B | $44.68B | 8 |
| 2029-02-28 | $46.63B | $48.18B | $49.03B | 14 |
| 2029-05-28 | $51.86B | $53.58B | $54.52B | 8 |
| 2029-05-31 | $176.05B | $183.24B | $185.60B | 17 |
| 2029-08-28 | $50.89B | $52.58B | $53.50B | 8 |
| 2029-11-28 | $53.38B | $55.16B | $56.13B | 13 |
| 2030-02-28 | $55.66B | $57.51B | $58.52B | 8 |
| 2030-05-28 | $58.13B | $60.07B | $61.12B | 12 |
| 2030-05-31 | $214.78B | $223.56B | $226.45B | 17 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-05-31 | $7.33 | $7.98 | $8.32 | 23 |
| 2028-05-31 | $7.36 | $10.78 | $14.05 | 16 |
| 2028-08-28 | $3.24 | $3.38 | $3.46 | 15 |
| 2028-11-28 | $3.65 | $3.81 | $3.90 | 9 |
| 2029-02-28 | $3.96 | $4.13 | $4.22 | 13 |
| 2029-05-28 | $4.49 | $4.69 | $4.80 | 7 |
| 2029-05-31 | $14.87 | $15.67 | $15.93 | 7 |
| 2029-08-28 | $4.43 | $4.62 | $4.73 | 7 |
| 2029-11-28 | $4.84 | $5.05 | $5.17 | 12 |
| 2030-02-28 | $5.16 | $5.39 | $5.51 | 7 |
| 2030-05-28 | $5.71 | $5.96 | $6.10 | 11 |
| 2030-05-31 | $19.48 | $20.53 | $20.88 | 7 |
Frequently Asked Questions
What is the analyst consensus for ORCL?
The consensus among 51 analysts covering Oracle Corporation (ORCL) is Buy with an average price target of $236.52.
What is the highest price target for ORCL?
The highest price target for ORCL is $400.00, set by Siti Panigrahi at Mizuho Securities on 2025-12-15.
What is the lowest price target for ORCL?
The lowest price target for ORCL is $66.00, set by Kash Rangan at Goldman Sachs on 2021-09-14.
How many analysts cover ORCL?
51 analysts have issued ratings for Oracle Corporation in the past 12 months.
Is ORCL a buy or sell right now?
Based on 51 analyst ratings, ORCL has a consensus rating of Buy (2.14/5) with a +78.4% upside to the consensus target of $236.52.
What are the earnings estimates for ORCL?
Analysts estimate ORCL will report EPS of $7.98 for the period ending 2027-05-31, with revenue estimated at $88.61B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.